Form 8-K - Current report:
SEC Accession No. 0001144204-14-062642
Filing Date
2014-10-24
Accepted
2014-10-23 20:31:20
Documents
26
Period of Report
2014-10-24
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v392039_8k.htm 8-K 16333
2 EXHIBIT 99.1 v392039_ex99-1.htm EX-99.1 44797
3 GRAPHIC image_001.jpg GRAPHIC 46354
4 GRAPHIC image_002.jpg GRAPHIC 121930
5 GRAPHIC image_003.jpg GRAPHIC 125416
6 GRAPHIC image_004.jpg GRAPHIC 123771
7 GRAPHIC image_005.jpg GRAPHIC 163250
8 GRAPHIC image_006.jpg GRAPHIC 110224
9 GRAPHIC image_007.jpg GRAPHIC 133096
10 GRAPHIC image_008.jpg GRAPHIC 114079
11 GRAPHIC image_009.jpg GRAPHIC 118733
12 GRAPHIC image_010.jpg GRAPHIC 130683
13 GRAPHIC image_011.jpg GRAPHIC 134620
14 GRAPHIC image_012.jpg GRAPHIC 111133
15 GRAPHIC image_013.jpg GRAPHIC 124216
16 GRAPHIC image_014.jpg GRAPHIC 108710
17 GRAPHIC image_015.jpg GRAPHIC 86939
18 GRAPHIC image_016.jpg GRAPHIC 89369
19 GRAPHIC image_017.jpg GRAPHIC 99434
20 GRAPHIC image_018.jpg GRAPHIC 110571
21 GRAPHIC image_019.jpg GRAPHIC 144713
22 GRAPHIC image_020.jpg GRAPHIC 136554
23 GRAPHIC image_021.jpg GRAPHIC 114472
24 GRAPHIC image_022.jpg GRAPHIC 113844
25 GRAPHIC image_023.jpg GRAPHIC 64596
26 GRAPHIC image_024.jpg GRAPHIC 125716
  Complete submission text file 0001144204-14-062642.txt   3858217
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
PLASMATECH BIOPHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 141170972
SIC: 2834 Pharmaceutical Preparations